​

Harbor MedTech, Inc. is a fully integrated, commercial-stage regenerative medicine company focused on advanced orthopedic soft tissue repair solutions using our patented BriDGE® technology.

​

Our BriDGE® Technology transforms readily available, intact Type-1 collagen into a bio-friendly, stabilized collagen matrix which acts as a trigger to activate the patient’s own healing cascade.

​

Pre-clinical and clinical experience has demonstrated that our BriDGE-processed collagen matrix, when applied to chronic skin wounds or internal soft tissue injuries, acts to:

​

• Accelerate wound healing;

• Activate & support tissue regeneration;

• Limit the formation of scar tissue and

• Limit the formation of infectious biofilm.

​

Harbor MedTech currently has two FDA-cleared & CE marked products, & a broad pipeline that leverages our patented BriDGE® Collagen Processing Technology. 

​

 

Our product pipeline is addressing:

 

• Orthobiologic Soft Tissue (Sports Medicine) injuries;

• General Surgical Repair of Hernia & Breast Reconstruction;

• Difficult to Heal Chronic Skin Wounds.

​